Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

Drugmaker expands manufacturing of popular prostate PET imaging agent
The move will make the Huntsman Cancer Institute the first academic medical center in the U.S. to produce Posluma, according to Blue Earth Diagnostics.
University launches clinical trial for groundbreaking nuclear medicine cancer treatment
The University of Missouri Research Reactor will play a key role in the trial, as it is the only domestic producer of Y-90.
Photon-counting CT offers numerous benefits in lung cancer imaging
Compared to conventional contrast-enhanced chest computed tomography, photon-counting CT exams can reduce patients' effective radiation dose by more than 66%.
Microsoft and Bristol Myers Squibb partner to advance AI-enabled lung cancer detection
Lung cancer remains the leading cause of cancer-related deaths in the United States. It is estimated that it claims approximately 125,000 lives in the U.S. every year.
New theranostic could potentially cure difficult-to-treat gastric and pancreatic cancers
Researchers believe new research findings relating to the PET technique signal its potential “to meaningfully change patient care.”

New radioummonotherapy may be more effective at treating ovarian cancer than current standard of care

The method targets cancer stem cells, which are highly tumorigenic and known to play a significant role in relapse, cancer spread and treatment resistance.

Philips UroNav system gains FDA clearance

FDA clears fusion image navigation system for prostate cancer therapy planning

The fusion technology integrates pre-procedural MR images of the prostate with intraprocedural ultrasound images in real-time.

Bacteria-based contrast agent lights up tumor margins significantly better than other agents.

Bacteria-based contrast agent offers 'substantial improvements' for tumor border delineation during surgery

Essentially, the agent places a bright neon sign on the entirety of tumors and their borders, and it does so autonomously.

AI ups detection of small prostate lesions by nearly 20%

Many experts believe that artifcial intelligence could help address issues with reader variability on prostate MRIs.

FDA approves expanded use of radioembolization therapy for liver cancer

The added indications make the treatment the first Y-90 therapy approved for both unresectable hepatocellular carcinoma and metastatic colorectal cancer of the liver.

radiology report bubbles translate informatics imaging

Most oncologists prefer cancer-specific structured radiology reports

Despite this, not all radiologists are on board with routinely using oncology templates.

doctor comparing the costs of different medical treatments

Post-ablation PET imaging may not be cost-effective in patients with liver metastases

Although most radiology organizations agree that [18F]FDG PET/CT can provide valuable information in these patients post-treatment, their recommendations differ on its use.

Industry partnership set to advance research on theranostics

The deal will create a Therapy Command Center to support the study and use of theranostics across Massachusetts General Hospital and its affiliated centers in bordering states.

Oncology Imaging

Drugmaker expands manufacturing of popular prostate PET imaging agent

University launches clinical trial for groundbreaking nuclear medicine cancer treatment

Photon-counting CT offers numerous benefits in lung cancer imaging

Microsoft and Bristol Myers Squibb partner to advance AI-enabled lung cancer detection

New theranostic could potentially cure difficult-to-treat gastric and pancreatic cancers